Physician profile
Andrew Cramer
NPI 1063077972
$4,038.96
in general payments reported to CMS, 2019-2025
8 companies · $2,809 in 2025
The $2,809 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $190 · 2023: $532 · 2024: $508 · 2025: $2,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,247 · Grant: $1,247 · Travel and Lodging: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,247.42 |
| Grant | $1,246.76 |
| Travel and Lodging | $355.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,496.91 | 2022-2025 | Mako, Salvation, Infinity Adaptis |
| Arthrex, INC. | $1,433.76 | 2025 | |
| Mid-Atlantic Surgical Systems, LLC | $673.31 | 2023-2025 | |
| Depuy Synthes Sales INC. | $168.94 | 2025 | Na, Motoband, Va-Lcp |
| Smith+Nephew, INC. | $100.00 | 2023 | Real Intelligence |
| Kerecis Limited | $91.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $59.19 | 2023 | Aquamantys(Tm) |
| Kci USA, INC. | $15.77 | 2023 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.